Cargando…
Closure, Anticoagulation, or Antiplatelet Therapy for Cryptogenic Stroke With Patent Foramen Ovale: Systematic Review of Randomized Trials, Sequential Meta‐Analysis, and New Insights From the CLOSE Study
BACKGROUND: We conducted a systematic review and meta‐analysis of randomized controlled trials (RCTs) comparing patent foramen ovale (PFO) closure, anticoagulation, and antiplatelet therapy to prevent stroke recurrence in patients with PFO‐associated cryptogenic stroke. METHODS AND RESULTS: We searc...
Autores principales: | Turc, Guillaume, Calvet, David, Guérin, Patrice, Sroussi, Marjorie, Chatellier, Gilles, Mas, Jean‐Louis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220551/ https://www.ncbi.nlm.nih.gov/pubmed/29910193 http://dx.doi.org/10.1161/JAHA.117.008356 |
Ejemplares similares
-
Patent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: a systematic review and network meta-analysis incorporating complementary external evidence
por: Mir, Hassan, et al.
Publicado: (2018) -
Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline
por: Kuijpers, Ton, et al.
Publicado: (2018) -
Correction: Patent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: a systematic review and network meta-analysis incorporating complementary external evidence
Publicado: (2018) -
Percutaneous closure of a patent foramen ovale after cryptogenic stroke
por: Snijder, R. J. R., et al.
Publicado: (2017) -
Patent foramen ovale closure reduces recurrent stroke risk in cryptogenic stroke: A systematic review and meta-analysis of randomized controlled trials
por: Anantha-Narayanan, Mahesh, et al.
Publicado: (2018)